Clinical Trial

Development and Investigation of the ApneaTheraPlay

Not Yet Recruiting
View on ClinicalTrials.gov →
Summary
Obstructive Sleep Apnea Syndrome (OSAS) is commonly treated with CPAP devices, but adherence rates are low. Exercise has been shown to strengthen respiratory muscles, improve upper airway function, and enhance sleep quality. However, most studies have examined only single or dual exercise protocols, and there is little evidence regarding integrated programs with four exercise types or their effects when performed directly before sleep. This project aims to develop and evaluate ApneaTheraPlay (ATP), a digital gamified video-based exercise platform combining respiratory, aerobic, strengthening, and oropharyngeal exercises. The randomized controlled, double-blind study will allocate participants into three groups: ATP, a structured pre-sleep exercise group (SPEG), and a control group (CG). Intervention groups will exercise three times per week for 12 weeks, while the control group will only keep a physical activity diary.
Protocol Amendment History 2 amendments
This ClinicalTrials.gov record has been amended 2 times since 2025-10-02; most recent amendment 2026-07-27.
Trial Details
NCT Number NCT07214636
Lead Sponsor Medipol University
Conditions Apnea, Obstructive, Exercise Addiction, Physiotherapy and Rehabilitation
Enrollment 54 participants
Start Date 2026-07-28
Primary Completion 2027-08-01 (estimated)
Study Completion 2027-12-01 (estimated)
Updated on ClinicalTrials.gov 2026-07-28